The table below shows CUMBERLAND PHARMACEUTICALS INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$387.02K
$3.90M
-$2.14M
-$1.42M
-$150.50K
$1.79M
Capital expenditure
$0.00
$47.63K
$41.62K
$107.26K
$26.99K
$19.46K
Investing cash flow
-$61.17K
-$1.23M
-$58.19K
-$174.45K
-$13.54M
-$318.34K
Dividends paid
-
-
-
-
CPIX operating cash flow (10-K history)
CUMBERLAND PHARMACEUTICALS INC reported operating cash flow of $4.93M for fiscal year 2025. That is up 905.7% from -$612.19K in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $569.48K (FY 2016) to $4.93M. Figures come from the company's audited annual reports as filed with the SEC.